Related Experiment Video
Updated: Aug 15, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Crystal structures of active SRC kinase domain complexes
Christine B Breitenlechner1, Norman A Kairies, Konrad Honold
1Abteilung Strukturforschung, Max-Planck-Institut für Biochemie, 82152 Martinsried, Germany.
Abstract:
c-Src was the first proto-oncoprotein to be identified, and has become the focus of many drug discovery programs. Src structures of a major inactive form have shown how the protein kinase is rigidified by several interdomain interactions; active configurations of Src are generated by release from this "assembled" or "bundled" form. Despite the importance of Src as a drug target, there is relatively little structural information available regarding the presumably more flexible active forms. Here we report three crystal structures of a dimeric active c-Src kinase domain, in an apo and two ligand complexed forms, with resolutions ranging from 2.9A to 1.95A. The structures show how the kinase domain, in the absence of the rigidifying interdomain interactions of the inactivation state, adopts a more open and flexible conformation. The ATP site inhibitor CGP77675 binds to the protein kinase with canonical hinge hydrogen bonds and also to the c-Src specific threonine 340. In contrast to purvalanol B binding in CDK2, purvalanol A binds in c-Src with a conformational change in a more open ATP pocket.
Insights
Structural studies reveal active c-Src kinase domain dynamics. New crystal structures show how inhibiting this proto-oncoprotein involves flexible conformations and specific ligand interactions, crucial for drug discovery.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- c-Src is a proto-oncoprotein and a key target in drug discovery.
- Inactive c-Src structures reveal rigid, assembled conformations.
- Limited structural data exists for active, flexible c-Src forms.
Purpose of the Study:
- To determine the structural basis of active c-Src kinase domain conformations.
- To investigate ligand binding in active c-Src.
- To provide insights into c-Src drug development.
Main Methods:
- X-ray crystallography
- Analysis of apo and ligand-bound c-Src kinase domain structures
- High-resolution structural determination (1.95Å–2.9Å)
Main Results:
- Three crystal structures of dimeric active c-Src kinase domain were determined.
- Active c-Src adopts a more open and flexible conformation compared to inactive states.
- Specific interactions of ATP-site inhibitors CGP77675 and purvalanol A with c-Src were elucidated.
Conclusions:
- The active c-Src kinase domain exhibits flexibility independent of interdomain interactions.
- Ligand binding reveals specific interactions, including with c-Src residue Threonine 340.
- Structural insights advance understanding of c-Src regulation and inform targeted drug design.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
MAPK Signaling Cascades
